quinuclidines has been researched along with Bladder, Overactive in 144 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 59 (40.97) | 29.6817 |
| 2010's | 85 (59.03) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaplan, SA | 1 |
| Ablove, T; Bell, LN; Chappell, RJ; Liang, H; Toklu, HZ; Yale, SH | 1 |
| Compion, G; Dale, M; Stow, B; Tretter, R; Wagg, A | 2 |
| Hsiao, SM; Kuo, HC; Lin, HH | 1 |
| Berouz, A; Ferrara, V; Giannubilo, W; Morosetti, C; Vecchioli-Scaldazza, C | 1 |
| Mauseth, SA; Skurtveit, S; Spigset, O | 1 |
| Abrams, P; Hart, WM; Munro, V; Nazir, J; Retsa, P | 1 |
| Braga, A; Cattoni, E; Cromi, A; Ghezzi, F; Salvatore, S; Serati, M; Siesto, G; Sorice, P; Uccella, S | 1 |
| Byun, SS; Kim, KH; Lee, JY; Lee, SH; Lee, SJ | 1 |
| Akino, H; Fujiuchi, Y; Fuse, H; Kitagawa, Y; Miyazawa, K; Namiki, M; Suzuki, K; Yokoyama, O | 1 |
| Arumi, D; Lizarraga, I; Miranda, P; Rejas, J; Sánchez-Ballester, F | 1 |
| Betz, D; Burger, M; Hampel, C; Vogel, M | 1 |
| Aguado-Jodar, A; Ibáñez-Nolla, J; Kvasz, M; Navarro-Artieda, R; Rejas, J; Ruiz-Torrejón, A; Sicras-Mainar, A | 1 |
| Braga, A; Ghezzi, F; Salvatore, S; Serati, M; Siesto, G; Sorice, P | 1 |
| Gotoh, M; Kobayashi, T; Sogabe, K | 1 |
| Walton, A | 1 |
| An, R; Guan, Z; Guo, H; He, D; Huang, J; Huang, Y; Kong, C; Li, H; Liao, L; Liu, M; Shen, Z; Song, B; Song, X; Sun, Y; Wang, D; Wang, J; Wang, X; Wen, J; Xiao, J; Yang, Y; Ye, Z; Zeng, P; Zhang, X; Zhao, X; Zheng, S | 1 |
| Guo, KC; Huo, LZ; Jing, HG; Luan, XH; Shi, BK; Wang, TC; Yuan, SX | 1 |
| Wein, AJ | 2 |
| Hart, WM; Nazir, J | 1 |
| Gao, ZW; Li, HB; Ren, XQ; Shang, YF; Shao, CS; Xiao, F; Xin, SY; Zhang, JG; Zhang, W | 1 |
| Cao, Z; Guo, F; Pan, A; Peng, S; Sun, Y; Wang, H; Wang, L; Wei, R; Xu, C; Zhang, C; Zhang, Z | 1 |
| Arslan, U; Dolen, I; Hekimoglu, E; Petricli, IS; Sekeroglu, MA; Tasci, Y | 1 |
| Adiloğlu, AK; Arslan, H; Aydın, A; Aydoğmuş, Y; Şahin, H; Sunay, M | 1 |
| Kosilov, KV; Kosilova, LV; Krasnykh, MA; Loparev, SA | 1 |
| Andersson, KE | 1 |
| Ivanovskaya, MA; Kosilov, KV; Kosilova, LV; Loparev, SA | 2 |
| Doo, SW; Kim, JH; Lee, SW; Yang, HJ; Yang, WJ; Yun, JH | 1 |
| Chung, BH; Hong, S; Kim, CS; Kim, DK; Kim, JC; Lee, JG; Lee, KS; Lee, YS; Park, CH; Park, JK | 1 |
| Li, J; Li, P; Liu, B; Wang, Y; Wu, Y | 1 |
| Choo, MS; Han, JY; Kim, DY; Kwon, DD; Lee, JG; Lee, JZ; Lee, KS; Na, YG; Park, CH; Park, WH | 1 |
| Cheon, SY; Cho, SY; Choi, JB; Choo, MS; Chun, JY; Kim, JC; Kim, JH; Lee, KS; Oh, SJ; Park, J; Seo, JT; Song, M | 1 |
| Borodulina, IV; Kadykov, AS; Kravchenko, MA; Popov, SV; Shvarts, PG; Vinarov, AZ | 1 |
| Hagiwara, M; Hasegawa, M; Ishioka, K; Kikuchi, E; Maeda, T; Miyajima, A; Miyazaki, Y; Oya, M; Shinojima, T | 1 |
| Kagan, OF; Kheĭfets, VKh; Sosnovskiĭ, SO | 2 |
| Masumori, N; Tanaka, Y; Tanuma, Y | 1 |
| Cruz, F | 1 |
| Bolodeoku, J; Khullar, V; Mundy, A; Odeyemi, I; Speakman, M | 1 |
| Widhalm, S | 1 |
| Capo, JP; Forero-Schwanhaeuser, S; Pelman, RS | 1 |
| Costa, AM; Galatioto, GP; Gravina, GL; Martella, O; Ronchi, P; Vicentini, C | 1 |
| Al, MJ; Hakkaart, L; Phillips, R; Verboom, P | 1 |
| Asajima, H; Matsushima, S; Saito, N; Saito, T; Sekiguchi, Y | 1 |
| Arañó, P; Bolodeoku, J; Cardozo, L; Dewilde, L; Drogendijk, T; Hessdörfer, E; Milani, R; Slack, M; Wright, M | 1 |
| Andoh, M; Fakhoury, A; Forero-Schwanhaeuser, S; Karram, MM; Serels, SR; Toglia, MR | 1 |
| Capo', JP; Chancellor, MB; Forero-Schwanhaeuser, S; Karram, M; Kobashi, K; Laramée, C; Nandy, I; Seifeldin, R; Siami, P; Snyder, JA; Whitmore, K; Zinner, N | 1 |
| Burcher, E; Chandran, JJ; Christopoulos, A; Mansfield, KJ; Millard, RJ; Mitchelson, FJ; Vaux, KJ | 1 |
| Choo, MS; Jung, HC; Kim, HJ; Kim, JC; Kim, YH; Lee, JB; Lee, JG; Lee, JZ; Lee, KS; Na, YG; Paick, JS; Seo, JT | 1 |
| Fabisovský, M; Havránek, O; Krhut, J; Míka, D; Valis, P | 1 |
| Schaefer, W | 1 |
| Duggan, P; Wong, C | 1 |
| Hoffstetter, S; Leong, FC | 1 |
| Forero-Schwanhaeuser, S; Siami, P; Swift, SE | 1 |
| Axelsen, S; Kulseng-Hansen, S; Mattiasson, A; Milsom, I; Nilsson, CG; Wickstrøm, J | 1 |
| Brenes, FJ; Chapple, CR; Rosenberg, MT | 1 |
| Andoh, M; Dmochowski, R; Forero-Schwanhaeuser, S; Sand, PK; Steers, WD | 1 |
| Iannazzo, S; Pradelli, L | 1 |
| Altman, D; Falconer, C; Granath, F; Mattiasson, A | 1 |
| De Caestecker, K; De Pooter, J; Dehoorne, J; Hoebeke, P; Raes, A; Van Laecke, E; Vande Walle, J | 1 |
| Bolodeoku, J; Masala, A; Mattiasson, A; Morton, R | 1 |
| Andoh, M; Forero-Schwanhaeuser, S; Karram, MM; Laramée, C; Nandy, IM; Seifeldin, R; Serels, SR; Toglia, MR | 1 |
| Fakhoury, A; Fincher, R; He, W; Kaplan, SA; McCammon, K | 2 |
| Forero-Schwanhaeuser, S; He, W; Marshall, TS; Mitcheson, HD; Samuels, TA; Vardy, MD; Wegenke, JD | 1 |
| Andoh, M; Forero-Schwanhaeuser, S; Gittelman, M; Goldfischer, ER; Kaplan, SA; Steers, WD | 1 |
| Marshall, T; Noe, L; Rasouliyan, L; Runken, MC; Seifeldin, R; Zinner, N | 1 |
| Cardozo, L; Sidhu, M; Thorpe, A; Warner, J | 1 |
| Miyata, K; Ohtake, A; Sasamata, M; Sato, S | 1 |
| Wyndaele, JJ | 1 |
| Barkin, J; Carlson, K; Drutz, H; Egerdie, B; Gajewski, JB; Herschorn, S; Paradiso-Hardy, F; Pommerville, P; Radomski, S; Schulz, J; Stothers, L | 1 |
| Andoh, M; Appell, RA; Fakhoury, A; Hussain, IF; Ostergard, DR; Toglia, MR | 1 |
| Santos, JC; Telo, ER | 1 |
| Masumori, N; Tanaka, Y; Tsukamoto, T | 1 |
| Herschorn, S; Piwko, C; Vicente, C | 1 |
| Forero-Schwanhaeuser, S; He, W; Serels, SR; Toglia, MR | 1 |
| Bolduc, S; Hamel, M; Lamontagne, P; Lebel, S; Moore, K; Nadeau, G | 1 |
| Chernev, T; Dimitrov, R; Doganov, N; Popov, E; Slavov, Ch; Slavov, S | 1 |
| Grinta, R; Vecchioli-Scaldazza, C | 1 |
| Chang, TC; Ho, CH; Huang, KH; Lin, HH; Liu, SP; Yu, HJ | 1 |
| Barkin, J; Carlson, K; Corcos, J; Drutz, H; Egerdie, B; Gajewski, J; Herschorn, S; Hirshberg, E; Pommerville, P; Radomski, S; Schulz, J; Stothers, L | 1 |
| Crosby, RD; Marshall, TS; Mathias, SD | 1 |
| Capo', JP; Forero-Schwanhaeuser, S; He, W; Lucente, V | 1 |
| de la Rosette, JJ; Michel, MC; Oelke, M; Vogel, M | 1 |
| Bungay, PJ; Callegari, E; Fenner, KS; Kay, GG; Kempshall, S; LaPerle, JL; Malhotra, B; Michel, MC; Webster, R | 1 |
| Schröder, A; Thüroff, JW | 1 |
| Chang, TC; Chen, CH; Hsiao, SM; Lin, HH; Wu, WY; Yu, HJ | 1 |
| Gotoh, M; Ishizuka, O; Itoh, N; Kakizaki, H; Okada, H; Ozono, S; Seki, N; Sugiyama, T; Yamada, S; Yamaguchi, O; Yokota, T; Yokoyama, O; Yoshida, M | 1 |
| Kalchthaler, M; Mühlich, S; Rothe, P | 2 |
| Gotoh, M; Homma, Y; Kakizaki, H; Nishizawa, O; Seki, N; Takeda, M; Yamaguchi, O; Yokoyama, O; Yoshida, M | 1 |
| Fukuhara, S; Matsuoka, Y; Miyagawa, Y; Nakayama, J; Nonomura, N; Takao, T; Tsujimura, A; Yamamoto, K | 1 |
| Kuo, HC; Lin, H; Liu, HT | 1 |
| Abrams, P; Chapple, CR; Jünemann, KP; Sharpe, S | 1 |
| Brubaker, L; Durazo-Arivzu, RA; Fitzgerald, MP; Kenton, K; Lowenstein, L; Mueller, ER; Sabo, E | 1 |
| Akino, H; Aoki, Y; Ito, H; Nagase, K; Tanase, K; Yokoyama, O | 1 |
| Cody, JD; Ellis, G; Hay-Smith, EJ; Herbison, GP; Madhuvrata, P | 1 |
| Han, P; Liu, L; Luo, D; Shen, H; Wei, Q | 1 |
| Cho, KS; Chung, JH; Ha, US; Ham, WS; Han, JH; Kang, DH; Lee, JY; Lee, SH; Lee, SW; Park, J; Yoo, TK | 1 |
| Banović, M; But, I; Goldstajn, MS; Oresković, S | 1 |
| Alessandri, F; Candiani, M; Ferrero, S; Leone Roberti Maggiore, U; Origoni, M; Remorgida, V; Salvatore, S; Venturini, PL | 1 |
| Ammann, LP; Bukofzer, S; Haas, GP; He, W; Janning, SW; Zinner, NR | 1 |
| Fukumoto, K; Hara, R; Koide, T; Miyaji, Y; Nagai, A; Yokoyama, T | 1 |
| Krebs, J; Pannek, J | 1 |
| Amarenco, G; Cardozo, L; Compion, G; Drogendijk, T; Mikulas, J; Pushkar, D; Wright, M | 1 |
| Jiang, XZ; Xu, C; Xu, ZS; Zhang, NZ; Zhao, HF | 1 |
| But, I; Goldstajn, MS; Oresković, S | 1 |
| Cornu, JN | 1 |
| Cardozo, L; Kelleher, C; Kobashi, K; Lucente, V | 1 |
| Cardozo, L; Castro-Diaz, D; Gittelman, M; Huang, M; Ridder, A | 1 |
| Goepel, M | 1 |
| Cardozo, L; Chapple, CR; Govier, FE; Steers, WD | 1 |
| Kreder, KJ | 1 |
| Hegde, SS; Michel, MC | 1 |
| Maniscalco, M; Singh-Franco, D; Torres-Colón, R; Wolowich, WR | 1 |
| Drinka, PJ | 1 |
| Chapple, CR | 1 |
| Brubaker, L; FitzGerald, MP | 1 |
| Ikeda, K; Miyata, K; Ohtake, A; Sasamata, M; Sato, S | 1 |
| Hatanaka, T; Miyata, K; Noguchi, Y; Ohtake, A; Okutsu, H; Saitoh, C; Sasamata, M; Sato, S; Suzuki, M; Ukai, M; Yuyama, H | 1 |
| Colaço, J; Gonçalves, V; Metello, J; Nogueira, B; Retto, H; Torgal, M; Vieira, A | 1 |
| Andoh, M; Garely, AD; Kaufman, JM; Sand, PK; Smith, N | 1 |
| Kelleher, C; Payne, CK | 1 |
| Combest, W; Kosier, JH; Newton, M | 1 |
| Cardozo, L; Cartwright, R; Robinson, D; Vella, M | 1 |
| Adekunle, R; Bilal, S; Fishwick, K; Khunda, A | 1 |
| Garely, AD; Lucente, V; Smith, N; Vapnek, J | 1 |
| Chapple, C | 1 |
| Burks, D; Garely, AD; Mallett, V; Smith, N | 1 |
| Bertozzi, R; Cipriani, S; Colli, E; Meschia, M; Montorsi, F; Olivieri, L; Parazzini, F | 1 |
| Bolodeoku, J; Chapple, CR; Fianu-Jonsson, A; Indig, M; Khullar, V; Mistry, A; Rosa, J; Scarpa, RM; Wright, DM | 1 |
| Colli, E; Digesu, GA; Olivieri, L | 1 |
| Gotoh, M; Ishizuka, O; Itoh, N; Kakizaki, H; Marui, E; Okada, H; Ozono, S; Seki, N; Sugiyama, T; Yamaguchi, O; Yokota, T; Yoshida, M | 1 |
| Cardozo, L; Drogendijk, TE; Huang, AM; Kuzmin, I; Lisec, M; Milard, R; Van Vierssen Trip, O | 1 |
| Capo', JP; Fakhoury, A; Forero-Schwanhaeuser, S; Laramée, C; Lucente, V | 1 |
| Hilas, O; Lam, S | 1 |
| Gach, JE; Shalders, K | 1 |
| Marshall, T; Noe, L; Rasouliyan, L; Seifeldin, R; Zinner, N | 1 |
| Feldman, LS; Pemmaraju, N | 1 |
26 review(s) available for quinuclidines and Bladder, Overactive
| Article | Year |
|---|---|
The use of pharmacotherapy for male patients with urgency and stress incontinence.
Topics: 5-alpha Reductase Inhibitors; Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Thiazoles; Urinary Bladder, Overactive; Urinary Incontinence, Stress; Urinary Incontinence, Urge; Urological Agents | 2014 |
[Comparisons of therapeutic efficacy and safety of solifenacin versus tolterodine in patients with overactive bladder: a meta-analysis of outcomes].
Topics: Benzhydryl Compounds; Constipation; Cresols; Humans; Phenylpropanolamine; Quinuclidines; Safety; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Xerostomia | 2014 |
[Current pharmacotherapy of overactive bladder in neurological patients].
Topics: Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urination; Urological Agents | 2014 |
Solifenacin at 3 years: a review of efficacy and safety.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Humans; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2008 |
Solifenacin succinate for the treatment of overactive bladder.
Topics: Animals; Clinical Trials as Topic; Female; Humans; Male; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2009 |
Listening to the patient: a flexible approach to the use of antimuscarinic agents in overactive bladder syndrome.
Topics: Benzofurans; Drug Administration Schedule; Humans; Mandelic Acids; Multicenter Studies as Topic; Muscarinic Antagonists; Patient Satisfaction; Pyrrolidines; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2009 |
The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: ameliorative effect of solifenacin succinate (Vesicare), a bladder-selective antimuscarinic agent, on overactive bladder symptoms, especially urgen
Topics: Adenosine Triphosphate; Afferent Pathways; Animals; Disease Models, Animal; Humans; Muscarinic Antagonists; Muscle Contraction; Quinuclidines; Rats; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2010 |
Solifenacin: scientific evidence in the treatment of overactive bladder.
Topics: Clinical Trials as Topic; Humans; Muscarinic Antagonists; Quality of Life; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2010 |
New strategies for medical management of overactive bladder in children.
Topics: Benzhydryl Compounds; Benzilates; Botulinum Toxins; Child; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quinuclidines; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination | 2010 |
Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndrome.
Topics: Endpoint Determination; Female; Humans; Male; Muscarinic Antagonists; Outcome Assessment, Health Care; Prevalence; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Young Adult | 2012 |
Which anticholinergic drug for overactive bladder symptoms in adults.
Topics: Adult; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence | 2012 |
Solifenacin for overactive bladder: a systematic review and meta-analysis.
Topics: Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2012 |
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Chronic Disease; Cresols; Drug Combinations; Female; Humans; Imidazoles; Mandelic Acids; Muscarinic Antagonists; Nocturia; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence | 2012 |
[Safety of solifenacin and tolterodine in the treatment of overactive bladder: a meta-analysis].
Topics: Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2012 |
Solifenacin significantly improves all symptoms of overactive bladder syndrome.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Muscarinic Antagonists; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2006 |
Solifenacin.
Topics: Clinical Trials as Topic; Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2006 |
Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2006 |
Solifenacin succinate for the treatment of symptoms of overactive bladder.
Topics: Clinical Trials as Topic; Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics | 2006 |
Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder.
Topics: Dose-Response Relationship, Drug; Female; Humans; Male; Molecular Structure; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2006 |
[Pharmacological and clinical profile of solifenacin succinate (Vesicare) developed as a new therapeutic agent for overactive bladder].
Topics: Animals; Clinical Trials as Topic; Humans; Muscarinic Antagonists; Muscle, Smooth; Quinuclidines; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder, Overactive; Urination | 2006 |
Redefining response in overactive bladder syndrome.
Topics: Double-Blind Method; Humans; Multicenter Studies as Topic; Muscarinic Antagonists; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2007 |
New developments in the treatment of urinary incontinence.
Topics: Administration, Cutaneous; Adrenergic Uptake Inhibitors; Benzofurans; Drug Therapy, Combination; Duloxetine Hydrochloride; Humans; Mandelic Acids; Muscarinic Antagonists; Pyrrolidines; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Thiophenes; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Stress | 2006 |
Number of daytime micturitions and volume voided per micturition in the evaluation of efficacy of drugs for overactive bladder: findings from randomized clinical trials.
Topics: Benzhydryl Compounds; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination | 2007 |
Update on drugs for overactive bladder syndrome.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2007 |
Overactive bladder treatments in early phase clinical trials.
Topics: Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Models, Animal; Drugs, Investigational; Guanidines; Humans; Mice; Muscarinic Antagonists; Quinuclidines; Receptors, Muscarinic; Sensitivity and Specificity; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2007 |
Pharmacologic management of overactive bladder.
Topics: Benzhydryl Compounds; Benzofurans; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2007 |
59 trial(s) available for quinuclidines and Bladder, Overactive
| Article | Year |
|---|---|
The effect of solifenacin on postvoid dribbling in women: results of a randomized, double-blind placebo-controlled trial.
Topics: Child; Double-Blind Method; Female; Humans; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2018 |
Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study.
Topics: Adult; Aged; Aged, 80 and over; Cross-Over Studies; Female; Humans; Middle Aged; Patient Satisfaction; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tibial Nerve; Transcutaneous Electric Nerve Stimulation; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urination; Urological Agents | 2013 |
Effects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study.
Topics: Adrenergic alpha-Antagonists; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive | 2014 |
[A combination of solifenacin succinate and naftopidil in the treatment of female overactive bladder].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Middle Aged; Muscarinic Antagonists; Naphthalenes; Piperazines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Young Adult | 2013 |
[Efficacy of combination therapy of tamsulosin and solifenacin for mild and moderate benign prostatic hyperplasia with overactive bladder].
Topics: Aged; Drug Therapy, Combination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2014 |
Solifenacin is able to improve the irritative symptoms after transurethral resection of bladder tumors.
Topics: Cystectomy; Cystitis; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Remission Induction; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urination Disorders | 2014 |
Acupuncture versus solifenacin for treatment of overactive bladder and its correlation with urine nerve growth factor levels: a randomized, placebo-controlled clinical trial.
Topics: Acupuncture Therapy; Adolescent; Adult; Biomarkers; Female; Humans; Middle Aged; Muscarinic Antagonists; Nerve Growth Factor; Quality of Life; Quinuclidines; Recovery of Function; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Turkey; Urinary Bladder; Urinary Bladder, Overactive; Urination; Urodynamics; Urological Agents; Young Adult | 2014 |
[Treatment of overactive bladder in older women increased doses of antimuscarinic drugs safe and effective alternative to existing methods].
Topics: Aged; Benzhydryl Compounds; Benzilates; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics | 2014 |
Comparative effectiveness of combined low- and standard-dose trospium and solifenacin for moderate overactive bladder symptoms in elderly men and women.
Topics: Age Factors; Aged; Benzilates; Drug Therapy, Combination; Female; Humans; Male; Muscarinic Antagonists; Nortropanes; Quinuclidines; Russia; Severity of Illness Index; Sex Factors; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics; Urological Agents | 2014 |
Can we decide the optimal initial treatment for male lower urinary tract symptoms patients with overactive bladder by the most bothersome symptom? A randomized, prospective, open-label study.
Topics: Aged; Decision Making; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostate; Quality of Life; Quinuclidines; Republic of Korea; Solifenacin Succinate; Sulfonamides; Symptom Assessment; Tamsulosin; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2014 |
A comparative study on the efficacy of solifenacin succinate in patients with urinary frequency with or without urgency.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2014 |
Decrease of risk of developing symptoms of OAB in elderly men and women treated with loop diuretic for hypertensive disease using solifenacin.
Topics: Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Furosemide; Humans; Hypertension; Inpatients; Longitudinal Studies; Male; Prospective Studies; Quinuclidines; Risk Factors; Russia; Sodium Potassium Chloride Symporter Inhibitors; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics | 2014 |
[Peculiarities of clinical course, diagnostics and treatment of overactive bladder in men older than 60 years].
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Prostatitis; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents | 2014 |
A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome.
Topics: Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Double-Blind Method; Humans; Markov Chains; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2008 |
Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity.
Topics: Aged; Humans; Male; Middle Aged; Muscarinic Antagonists; Muscle Contraction; Perception; Prospective Studies; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics | 2009 |
Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination Disorders; Urodynamics | 2008 |
Treatment with solifenacin increases warning time and improves symptoms of overactive bladder: results from VENUS, a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Urinary Bladder, Overactive; Urination | 2009 |
Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study.
Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2008 |
Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nocturia; Patient Satisfaction; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urinary Retention | 2008 |
[Efficacy and safety of solifenacin in daily clinical practice--clinical study phase IV].
Topics: Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2008 |
Solifenacin for overactive bladder in women unsuccessfully treated with immediate release oxybutynin: a pilot study.
Topics: Adult; Aged; Cholinergic Antagonists; Female; Humans; Mandelic Acids; Middle Aged; Nocturia; Pilot Projects; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Failure; Urinary Bladder, Overactive | 2009 |
Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study.
Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2009 |
Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Behavior Therapy; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Young Adult | 2010 |
Solifenacin for overactive bladder: patient-reported outcomes from a large placebo-controlled trial.
Topics: Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2009 |
Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2009 |
Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT - a double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Young Adult | 2009 |
Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes.
Topics: Aged; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2010 |
Tolerability of 5 mg solifenacin once daily versus 5 mg oxybutynin immediate release 3 times daily: results of the VECTOR trial.
Topics: Adult; Aged; Aged, 80 and over; Canada; Chi-Square Distribution; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Xerostomia | 2010 |
Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status.
Topics: Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urinary Incontinence | 2010 |
Canadian cost-effectiveness analysis of solifenacin compared to oxybutynin immediate-release in patients with overactive bladder.
Topics: Canada; Cost-Benefit Analysis; Female; Humans; Male; Mandelic Acids; Markov Chains; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2010 |
Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Medical Records; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Placebos; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urination; Young Adult | 2010 |
Prospective open label study of solifenacin for overactive bladder in children.
Topics: Child; Female; Humans; Male; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urinary Incontinence | 2010 |
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Taiwan; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination | 2010 |
Tolerability of solifenacin and oxybutynin immediate release in older (> 65 years) and younger (≤ 65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Canada; Dosage Forms; Double-Blind Method; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Young Adult | 2011 |
Relationships between symptoms, symptom bother, and health-related quality of life in patients with overactive bladder taking solifenacin or placebo in the VIBRANT study.
Topics: Analysis of Variance; Female; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Patient Satisfaction; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2011 |
Which single-item measures of overactive bladder symptom treatment correlate best with patient satisfaction?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Health Status; Humans; Male; Middle Aged; Muscarinic Antagonists; Outcome Assessment, Health Care; Patient Satisfaction; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2011 |
Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome.
Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urodynamics | 2011 |
Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary.
Topics: Aged; Double-Blind Method; Female; Humans; Japan; Male; Medical Records; Middle Aged; Muscarinic Antagonists; Nocturia; Quinuclidines; Sleep; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2011 |
[Treatment with solifenacin reduces urinary urgency and improves quality of life. Results of the non-interventional CAP-study].
Topics: Adult; Aged; Cooperative Behavior; Female; Germany; Humans; Interdisciplinary Communication; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics | 2011 |
Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms--ASSIST, randomized controlled study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Prostatism; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2011 |
Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: an open-label, multicenter, prospective study.
Topics: Adult; Female; Humans; Hydrocephalus, Normal Pressure; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics; Ventriculoperitoneal Shunt | 2012 |
The efficacy and safety of solifenacin in patients with overactive bladder syndrome.
Topics: Aged; Female; Humans; Middle Aged; Muscarinic Antagonists; Placebos; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2012 |
Long-term safety and efficacy of two different antimuscarinics, imidafenacin and solifenacin, for treatment of overactive bladder: a prospective randomized controlled study.
Topics: Aged; Female; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder, Overactive; Xerostomia | 2013 |
Safety and tolerability of solifenacin add-on therapy to α-blocker treated men with residual urgency and frequency.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2013 |
Severity of overactive bladder symptoms and response to dose escalation in a randomized, double-blind trial of solifenacin (SUNRISE).
Topics: Administration, Oral; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2013 |
Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Analysis of Variance; Attention; Cognition; Cognitive Dysfunction; Cross-Over Studies; Double-Blind Method; Female; Humans; Least-Squares Analysis; Male; Mandelic Acids; Memory; Muscarinic Antagonists; Quinuclidines; Risk Factors; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; United Kingdom; Urinary Bladder, Overactive; Urological Agents | 2013 |
Comparison of two selective muscarinic receptor antagonists (solifenacin and darifenacin) in women with overactive bladder--the SOLIDAR study.
Topics: Benzofurans; Female; Humans; Middle Aged; Muscarinic Antagonists; Prospective Studies; Pyrrolidines; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2012 |
Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence.
Topics: Aged; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2006 |
Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin.
Topics: Adult; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Muscarinic Antagonists; Population; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2006 |
Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms.
Topics: Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nocturia; Polyuria; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2007 |
Comparison of the efficacy and tolerability of solifenacin succinate with or without previous use of trospium chloride.
Topics: Aged; Analgesics; Benzilates; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Middle Aged; Muscarinic Antagonists; Nortropanes; Prospective Studies; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2007 |
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; United States; Urinary Bladder, Overactive | 2006 |
Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Constipation; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Visual Acuity; Xerostomia | 2007 |
Solifenacin treatment for overactive bladder in black patients: patient-reported symptom bother and health-related quality of life outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black or African American; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2007 |
Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg.
Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Safety; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Stress; Urination | 2007 |
Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder.
Topics: Adult; Aged; Benzilates; Constipation; Double-Blind Method; Female; Humans; Japan; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Xerostomia | 2007 |
[A placebo-controlled, double-blind, randomized trial of single daily dose of anti-muscarinic drug solifenacin succinate in patients with overactive bladder].
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2007 |
Solifenacin treatment for overactive bladder in Hispanic patients: patient-reported symptom bother and quality of life outcomes from the VESIcare Open-Label Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Attitude to Health; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2008 |
Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER.
Topics: Activities of Daily Living; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Health Services; Humans; Male; Middle Aged; Muscarinic Antagonists; Outcome Assessment, Health Care; Patient Acceptance of Health Care; Phenylpropanolamine; Quality of Life; Quinuclidines; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2008 |
59 other study(ies) available for quinuclidines and Bladder, Overactive
| Article | Year |
|---|---|
Re: Effectiveness of Solifenacin and Trospium for Managing of Severe Symptoms of Overactive Bladder in Patients with Benign Prostatic Hyperplasia.
Topics: Humans; Male; Muscarinic Antagonists; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Urinary Bladder, Overactive | 2017 |
Reply from authors re: Jean-Nicolas Cornu. Overactive bladder medical management in the elderly: it is time to go beyond the tip of the iceberg. Eur Urol 2013;64:82-3.
Topics: Aging; Cognition; Cognitive Dysfunction; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urological Agents | 2013 |
Factors associated with a better therapeutic effect of solifenacin in patients with overactive bladder syndrome.
Topics: Aged; Area Under Curve; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Muscarinic Antagonists; Product Surveillance, Postmarketing; Prospective Studies; Quinuclidines; ROC Curve; Sex Factors; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics; Urological Agents | 2014 |
Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Benzofurans; Cholinergic Antagonists; Cresols; Databases, Pharmaceutical; Drug Substitution; Female; Follow-Up Studies; Humans; Medication Adherence; Middle Aged; Norway; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Young Adult | 2013 |
Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom.
Topics: Benzhydryl Compounds; Cohort Studies; Cost-Benefit Analysis; Cresols; Humans; Incontinence Pads; Mandelic Acids; Markov Chains; Medication Adherence; Models, Economic; Muscarinic Antagonists; Patient Dropouts; Phenylpropanolamine; Quality-Adjusted Life Years; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; United Kingdom; Urinary Bladder, Overactive; Urinary Incontinence | 2013 |
Risk factors for the failure of antimuscarinic treatment with solifenacin in women with overactive bladder.
Topics: Aged; Female; Humans; Middle Aged; Multivariate Analysis; Muscarinic Antagonists; Prospective Studies; Quality of Life; Quinuclidines; Risk Factors; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Time Factors; Treatment Failure; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2013 |
Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: results of a real-life clinical study.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Benzilates; Cresols; Cross-Sectional Studies; Female; Humans; Imidazoles; Japan; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2014 |
Therapeutic benefit in patients switching tolterodine to other novel antimuscarinic agents.
Topics: Activities of Daily Living; Adult; Aged; Benzhydryl Compounds; Comorbidity; Cresols; Cross-Sectional Studies; Drug Substitution; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Muscarinic Antagonists; Observational Studies as Topic; Patient Preference; Patient Satisfaction; Personal Satisfaction; Phenylpropanolamine; Physicians; Propensity Score; Quinuclidines; Retrospective Studies; Sample Size; Solifenacin Succinate; Tetrahydroisoquinolines; Therapeutic Equivalency; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents; Young Adult | 2014 |
Efficacy and tolerability of solifenacin in men with overactive bladder: results of an observational study.
Topics: Adult; Aged; Aged, 80 and over; Cognition; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2014 |
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain.
Topics: Aged; Benzhydryl Compounds; Cholinergic Agents; Cost-Benefit Analysis; Cresols; Female; Health Care Costs; Humans; Male; Phenylpropanolamine; Prevalence; Primary Health Care; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Spain; Syndrome; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2013 |
Solifenacin in women with de novo overactive bladder after tension-free obturator vaginal tape--is it effective?
Topics: Aged; Aged, 80 and over; Female; Humans; Middle Aged; Muscarinic Antagonists; Postoperative Complications; Prospective Studies; Quinuclidines; Solifenacin Succinate; Suburethral Slings; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2014 |
Impact of symptom improvement on patients' bother and quality of life in female patients with overactive bladder treated by solifenacin (SET-Q).
Topics: Aged; Aged, 80 and over; Female; Humans; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Symptom Assessment; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2014 |
Managing overactive bladder symptoms in a palliative care setting.
Topics: Aged, 80 and over; Butylscopolammonium Bromide; Cholinergic Antagonists; Humans; Incontinence Pads; Male; Muscarinic Antagonists; Palliative Care; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urinary Tract Infections | 2014 |
Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptoms.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2014 |
Re: randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.
Topics: Aging; Cognition; Cognitive Dysfunction; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Quinuclidines; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urological Agents | 2014 |
The cost-effectiveness of solifenacin vs. trospium in the treatment of patients with overactive bladder in the German National Health Service.
Topics: Benzilates; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Germany; Health Services; Humans; Medication Adherence; Models, Economic; National Health Programs; Nortropanes; Quality-Adjusted Life Years; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; United Kingdom; Urinary Bladder, Overactive; Urological Agents | 2014 |
The effect of oral solifenacin succinate treatment on intraocular pressure: glaucoma paradox during overactive bladder treatment.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2014 |
Re: risk factors for the failure of antimuscarinic treatment with solifenacin in women with overactive bladder.
Topics: Female; Humans; Muscarinic Antagonists; Quinuclidines; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2014 |
Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy.
Topics: Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2014 |
A prospective, observational study to assess the association between dry mouth and solifenacin treatment in patients with overactive bladder syndrome.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Xerostomia; Young Adult | 2015 |
Solifenacin or mirabegron could improve persistent overactive bladder symptoms after dutasteride treatment in patients with benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Aged, 80 and over; Azasteroids; Dutasteride; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Thiazoles; Urinary Bladder, Overactive | 2015 |
[ASSESSMENT OF EFFICIENCY OF TREATMENT OF OVERACTIVE BLADDER IN ELDERLY PATIENTS].
Topics: Adrenergic alpha-1 Receptor Antagonists; Age Factors; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Prazosin; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2015 |
Long-term prospective study of the persistence of solifenacin succinate in previously untreated Japanese female patients with overactive bladder.
Topics: Female; Humans; Medication Adherence; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2016 |
Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE).
Topics: Acetanilides; Double-Blind Method; Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive | 2016 |
[Overactive bladder. When it's pressing, immediate help is indicated].
Topics: Clinical Trials as Topic; Female; Humans; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics | 2008 |
The cost utility of solifenacin in the treatment of overactive bladder.
Topics: Adult; Cost-Benefit Analysis; Diapers, Adult; Drug Costs; Female; Humans; Male; Markov Chains; Muscarinic Antagonists; Patient Compliance; Quality-Adjusted Life Years; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2009 |
QT prolongation and torsade de pointes associated with solifenacin in an 81-year-old woman.
Topics: Aged, 80 and over; Electrocardiography; Female; Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Syncope; Tetrahydroisoquinolines; Torsades de Pointes; Treatment Outcome; Urinary Bladder, Overactive | 2008 |
[Urinary urgency].
Topics: Aged; Clinical Trials as Topic; Female; Humans; Male; Muscarinic Antagonists; Nocturia; Quinuclidines; Sleep Deprivation; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urinary Incontinence, Urge | 2008 |
Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
Topics: Aged; Benzhydryl Compounds; Benzofurans; Cresols; Cystectomy; Female; Humans; Male; Middle Aged; Mucous Membrane; Muscarinic Antagonists; Phenylpropanolamine; Prostatectomy; Pyrrolidines; Quinuclidines; Quinuclidinyl Benzilate; Radioligand Assay; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive | 2009 |
Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Humans; Muscarinic Antagonists; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Terminology as Topic; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2009 |
Cost-effectiveness analysis of solifenacin flexible dosing in patients with overactive bladder symptoms in four Nordic countries.
Topics: Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Decision Support Techniques; Female; Finland; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Scandinavian and Nordic Countries; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2009 |
Patient-reported most bothersome symptoms in OAB: post hoc analysis of data from a large, open-label trial of solifenacin.
Topics: Aged; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2009 |
Solifenacin in the treatment of overactive bladder syndrome in Italian patients: pharmacoeconomic evaluation.
Topics: Benzhydryl Compounds; Computer Simulation; Cost-Benefit Analysis; Cresols; Humans; Italy; Markov Chains; Muscarinic Antagonists; Pharmacogenetics; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence | 2009 |
Anticholinergic drug use for overactive bladder in Sweden: a nationwide pharmacoepidemiological study.
Topics: Benzhydryl Compounds; Benzofurans; Cholinergic Antagonists; Cresols; Female; Health Care Costs; Humans; Muscarinic Antagonists; Pharmacoepidemiology; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Registries; Retrospective Studies; Solifenacin Succinate; Sweden; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2009 |
Solifenacin for therapy resistant overactive bladder.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Male; Muscarinic Antagonists; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2009 |
Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: an exploratory subgroup analysis.
Topics: Aged; Efficiency; Female; Health Resources; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2009 |
The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service.
Topics: Benzhydryl Compounds; Benzilates; Cost-Benefit Analysis; Cresols; Decision Trees; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2010 |
Pediatrics: combining antimuscarinics shows promise for overactive bladder.
Topics: Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Pediatrics; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2010 |
Urodynamic effects of solifenacin in untreated female patients with symptomatic overactive bladder.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urodynamics | 2010 |
[Solifenacin in treatment of the overactive bladder syndrome--diagnosis, clinical management and results].
Topics: Aged; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urinary Incontinence | 2010 |
Overactive bladder syndrome: what is the role of evidence of detrusor overactivity in the cystometric study?
Topics: Adult; Aged; Aged, 80 and over; Cystostomy; Female; Humans; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Stress; Urodynamics | 2010 |
Efficacy and tolerability of solifenacin in patients aged ≥ 65 years with overactive bladder: post-hoc analysis of 2 open-label studies.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2011 |
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Benzhydryl Compounds; Benzofurans; Blood-Brain Barrier; Brain; Cell Line; Chromatography, High Pressure Liquid; Cresols; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Solifenacin Succinate; Tandem Mass Spectrometry; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2011 |
Solifenacin may improve sleep quality in patients with overactive bladder and sleep disturbance.
Topics: Aged; Humans; Male; Middle Aged; Muscarinic Antagonists; Nocturia; Quinuclidines; Sleep Wake Disorders; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urinary Incontinence, Urge | 2011 |
[Treatment for overactive bladder].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cooperative Behavior; Cross-Sectional Studies; General Practice; Humans; Interdisciplinary Communication; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Quinuclidines; Sex Factors; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urodynamics; Young Adult | 2011 |
Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Creatinine; Drug Resistance; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nerve Growth Factor; Quinuclidines; Solifenacin Succinate; Syndrome; Taiwan; Tetrahydroisoquinolines; Time Factors; Treatment Failure; Up-Regulation; Urinary Bladder; Urinary Bladder, Overactive; Young Adult | 2011 |
Solifenacin objectively decreases urinary sensation in women with overactive bladder syndrome.
Topics: Aged; Diagnostic Techniques, Urological; Equipment Design; Female; Follow-Up Studies; Humans; Middle Aged; Muscarinic Antagonists; Predictive Value of Tests; Quinuclidines; Reproducibility of Results; Sensation; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics | 2012 |
Co-administration of an α(1) -blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity.
Topics: Adrenergic alpha-1 Receptor Antagonists; Analysis of Variance; Animals; Disease Models, Animal; Diterpenes; Drug Therapy, Combination; Female; Infarction, Middle Cerebral Artery; Muscarinic Antagonists; Muscle Contraction; Organ Size; Quinuclidines; Rats; Rats, Sprague-Dawley; Solifenacin Succinate; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder, Overactive | 2011 |
Finding unrecognized information in overactive bladder clinical trial data: a new approach to understanding placebo and treatment effects.
Topics: Clinical Trials as Topic; Forecasting; Humans; Logistic Models; Models, Biological; Muscarinic Antagonists; Placebo Effect; Placebos; Quinuclidines; Randomized Controlled Trials as Topic; Retrospective Studies; Sample Size; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2013 |
Effects of solifenacin in patients with neurogenic detrusor overactivity as a result of spinal cord lesion.
Topics: Chi-Square Distribution; Compliance; Female; Humans; Longitudinal Studies; Male; Muscarinic Antagonists; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Spinal Cord Injuries; Switzerland; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics | 2013 |
Overactive bladder medical management in the elderly: it is time to go beyond the tip of the iceberg.
Topics: Aging; Cognition; Cognitive Dysfunction; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urological Agents | 2013 |
[Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder].
Topics: Analysis of Variance; Benzhydryl Compounds; Controlled Clinical Trials as Topic; Cresols; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2006 |
Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: A pooled analysis.
Topics: Aged; Gastroesophageal Reflux; Humans; Meta-Analysis as Topic; Muscarinic Antagonists; Quinuclidines; Respiratory Aspiration; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2006 |
Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
Topics: Animals; Atropine; Benzhydryl Compounds; Benzilates; Benzofurans; Binding, Competitive; Carbachol; CHO Cells; Cholinergic Agonists; Cresols; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Transfection; Urinary Bladder; Urinary Bladder, Overactive; Urination | 2007 |
Solifenacin succinate (VESIcare): overactive bladder therapy.
Topics: Contraindications; Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2006 |
An unusual cause of postoperative detrusor overactivity.
Topics: Adult; Fallopian Tube Diseases; Female; Humans; Hysterectomy; Muscarinic Antagonists; Prolapse; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urodynamics | 2007 |
[Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder].
Topics: Analysis of Variance; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2007 |
Photodistributed lichenoid drug eruption secondary to solifenacin.
Topics: Anti-Ulcer Agents; Anticholesteremic Agents; Drug Eruptions; Drug Interactions; Humans; Lichenoid Eruptions; Male; Middle Aged; Muscarinic Antagonists; Myocardial Ischemia; Quinine; Quinuclidines; Solifenacin Succinate; Sunscreening Agents; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive | 2008 |
Solifenacin-induced small bowel pseudo-obstruction.
Topics: Aged, 80 and over; Female; Humans; Intestinal Pseudo-Obstruction; Intestine, Small; Muscarinic Antagonists; Positron-Emission Tomography; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tomography, X-Ray; Urinary Bladder, Overactive | 2008 |